Kavontae Smalls is a Communications Specialist at SurvivorNet. He focuses on various aspects of medicine and healthcare, including consumer health, mental health, oncology, and palliative care, while also exploring healthcare technology and alternative medicine. Kavontae's work has been featured in Atlanta Black Star, SurvivorNet, NewsBreak, and MSN.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Kavontae Smalls' articles predominantly cover stories related to health, cancer, and celebrity health. The majority of the content features expert commentary and profile features. To effectively reach out to Kavontae, consider providing access to experts in the field of cancer research or treatment who can offer valuable insights into new developments or provide unique perspectives on trending topics in cancer awareness and treatment.
Given Kavontae's focus on covering profiles of public figures dealing with health challenges, consider offering interviews with individuals who have overcome significant health obstacles or professionals who work closely with celebrities facing similar issues.
While there is no specified geographic focus for Kavontae's coverage, her interest seems centered around international news involving prominent personalities which could be relevant when considering potential sources.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Kavontae Smalls
Two years after entering remission from medulloblastoma, a form of brain cancer, Isabella Strahan, 21, is back to her life as she knew it before cancer, while her father, “Good Morning America” host Michael Strahan, 54, reflects on the fear and helplessness he felt during her diagnosis and treatment.
By: Kavontae Smalls
Chronic lymphocytic leukemia typically progresses slowly, which gives most patients more time to gather information through a second opinion, consult another specialist, and make a confident, informed decision about their next steps.
By: Kavontae Smalls
Chronic lymphocytic leukemia (CLL) treatment today is highly individualized, with oncologists and patients working together to choose therapies based on medical factors, lifestyle needs, and personal values.
By: Kavontae Smalls
Fans have raised concerns after spotting what appears to be a lump on “Love Island” star Trinity Tatum’s neck, echoing past instances where reality TV view
By: Kavontae Smalls
Written by: Kavontae Smalls 0 seconds of 0 seconds Volume 0% FDA Approves a Promising New Option for People Facing Multiple Myeloma
By: Kavontae Smalls
mRNA Vaccine Shows Promise in Preventing Melanoma's Return A new personalized mRNA vaccine, intismeran autogene, significantly reduced the
By: Kavontae Smalls
Melanoma is highly aggressive and can return even after treatment, but a new personalized mRNA vaccine (intismeran) is showing early promise in preventing
By: Kavontae Smalls
Immunotherapy is a treatment that has expanded rapidly in recent years for lung cancer patients and helps many patients live longer with fewer side effects
By: Kavontae Smalls
A Powerful New First‑Line Option for HER2‑Positive Gastric and GEJ Cancer
By: Kavontae Smalls
0 seconds of 0 seconds Volume 0% A Personalized Melanoma Vaccine Offers Fresh Hope Against Recurrence and Spread
